European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

Recording: From clinical trial (ARAMIS, PROSPER, SPARTAN) to Real life. How to identify nmCRPC patient that can benefit from 2nd Gen ARIs?

Published Tue, 19 Oct 2021
Recorded WebinarProstate CancerOncology
OrganiserEuropean School of Urology (ESU)
CMENot approved
DurationApprox. 60 minutes

By 2021, it is standard of care to use one of the new androgen receptor inhibitors (ARIs) in high-risk non-metastatic castration-resistant prostate cancer (nmCRPC).

This has a major impact on time to metastases and even better on survival, based on the 3 randomized clinical trials. However, several questions remain:

- Which patients will truly benefit?

- How do we choose among the 3 available drugs and what about their impact on Quality of Life?

- What is the real value, if any, of the new imaging modalities?

The purpose of this UROwebinar is to clarify these questions to improve our daily practice which will lead to the delivery of optimal care.


Contact our organiser

European School of Urology (ESU)

Email:  educationonline@uroweb.org

Share this event

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer